Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)
China
· Delayed Price · Currency is CNY 15.56
+0.05 (0.32%)
Apr 29, 2026, 3:00 PM CST
SHA:600129 Revenue
In the year 2025, Chongqing Taiji Industry(Group) Co.,Ltd had annual revenue of 10.50B CNY, down -15.23%. Chongqing Taiji Industry(Group) Co.,Ltd had revenue of 2.41B in the quarter ending December 31, 2025, with 23.57% growth.
Revenue
10.50B
Revenue Growth
-15.23%
P/S Ratio
0.84
Revenue / Employee
938.92K
Employees
10,864
Market Cap
8.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.50B | -1.89B | -15.23% |
| Dec 31, 2024 | 12.39B | -3.24B | -20.72% |
| Dec 31, 2023 | 15.62B | 1.50B | 10.58% |
| Dec 31, 2022 | 14.13B | 1.98B | 16.28% |
| Dec 31, 2021 | 12.15B | 941.63M | 8.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Frontier Biotechnologies | 392.19M |
| Zhejiang Xianju Pharmaceutical | 3.76B |
| Shandong Lukang Pharmaceutical | 5.71B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.14B |
| Shenzhen Neptunus Bioengineering | 27.28B |
| Hunan Er-Kang Pharmaceutical | 1.06B |
| Jiuzhitang | 2.23B |
| North China Pharmaceutical Company.Ltd | 8.82B |